Clinical Trial Update: Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ipilimumab and nivolumab in nasopharyngeal carcinoma is in progress with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN